Zinc in PDB 5sf5: Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine, PDB code: 5sf5
was solved by
C.Joseph,
K.Groebke-Zbinden,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.82 /
1.98
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.992,
135.992,
236.077,
90,
90,
120
|
R / Rfree (%)
|
17.8 /
22.3
|
Other elements in 5sf5:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
(pdb code 5sf5). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine, PDB code: 5sf5:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5sf5
Go back to
Zinc Binding Sites List in 5sf5
Zinc binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:32.8
occ:1.00
|
O
|
A:HOH945
|
2.1
|
26.2
|
1.0
|
NE2
|
A:HIS529
|
2.1
|
31.8
|
1.0
|
O
|
A:HOH987
|
2.1
|
29.1
|
1.0
|
OD2
|
A:ASP564
|
2.2
|
29.8
|
1.0
|
OD1
|
A:ASP674
|
2.2
|
30.9
|
1.0
|
NE2
|
A:HIS563
|
2.2
|
25.7
|
1.0
|
CD2
|
A:HIS563
|
3.0
|
23.8
|
1.0
|
CG
|
A:ASP674
|
3.1
|
30.2
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
28.6
|
1.0
|
CG
|
A:ASP564
|
3.1
|
32.3
|
1.0
|
CE1
|
A:HIS529
|
3.1
|
30.9
|
1.0
|
CE1
|
A:HIS563
|
3.3
|
30.4
|
1.0
|
OD2
|
A:ASP674
|
3.4
|
34.6
|
1.0
|
OD1
|
A:ASP564
|
3.6
|
26.5
|
1.0
|
MG
|
A:MG802
|
3.8
|
26.8
|
1.0
|
O
|
A:HOH1026
|
4.1
|
26.1
|
1.0
|
CD2
|
A:HIS525
|
4.2
|
31.4
|
1.0
|
O
|
A:HOH918
|
4.2
|
33.1
|
1.0
|
CG
|
A:HIS563
|
4.2
|
26.7
|
1.0
|
ND1
|
A:HIS529
|
4.3
|
29.0
|
1.0
|
CG
|
A:HIS529
|
4.3
|
31.1
|
1.0
|
CB
|
A:ASP564
|
4.3
|
29.6
|
1.0
|
ND1
|
A:HIS563
|
4.3
|
28.3
|
1.0
|
NE2
|
A:HIS525
|
4.4
|
30.9
|
1.0
|
CB
|
A:ASP674
|
4.4
|
28.5
|
1.0
|
O
|
A:HOH931
|
4.6
|
22.9
|
1.0
|
CG2
|
A:VAL533
|
4.7
|
25.5
|
1.0
|
O
|
A:ASP674
|
4.8
|
29.6
|
1.0
|
CA
|
A:ASP674
|
4.9
|
27.2
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5sf5
Go back to
Zinc Binding Sites List in 5sf5
Zinc binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:31.6
occ:1.00
|
O
|
B:HOH969
|
2.1
|
20.6
|
1.0
|
OD1
|
B:ASP674
|
2.1
|
24.6
|
1.0
|
NE2
|
B:HIS563
|
2.2
|
25.4
|
1.0
|
NE2
|
B:HIS529
|
2.2
|
27.2
|
1.0
|
OD2
|
B:ASP564
|
2.2
|
26.3
|
1.0
|
O
|
B:HOH981
|
2.3
|
32.1
|
1.0
|
CG
|
B:ASP674
|
3.0
|
25.6
|
1.0
|
CD2
|
B:HIS563
|
3.1
|
24.6
|
1.0
|
CG
|
B:ASP564
|
3.2
|
26.3
|
1.0
|
CD2
|
B:HIS529
|
3.2
|
27.2
|
1.0
|
CE1
|
B:HIS529
|
3.2
|
28.6
|
1.0
|
CE1
|
B:HIS563
|
3.2
|
24.7
|
1.0
|
OD2
|
B:ASP674
|
3.3
|
24.8
|
1.0
|
OD1
|
B:ASP564
|
3.6
|
25.5
|
1.0
|
MG
|
B:MG802
|
3.8
|
24.5
|
1.0
|
O
|
B:HOH950
|
4.0
|
33.2
|
1.0
|
O
|
B:HOH1015
|
4.0
|
24.0
|
1.0
|
CD2
|
B:HIS525
|
4.1
|
26.8
|
1.0
|
CG
|
B:HIS563
|
4.2
|
24.0
|
1.0
|
ND1
|
B:HIS563
|
4.3
|
25.4
|
1.0
|
ND1
|
B:HIS529
|
4.3
|
23.5
|
1.0
|
NE2
|
B:HIS525
|
4.3
|
29.8
|
1.0
|
CG
|
B:HIS529
|
4.3
|
24.9
|
1.0
|
CB
|
B:ASP564
|
4.4
|
24.6
|
1.0
|
CB
|
B:ASP674
|
4.4
|
25.5
|
1.0
|
O
|
B:HOH942
|
4.6
|
28.2
|
1.0
|
CG2
|
B:VAL533
|
4.8
|
23.3
|
1.0
|
O
|
B:HOH1061
|
4.8
|
37.6
|
1.0
|
CA
|
B:ASP674
|
4.9
|
23.6
|
1.0
|
O
|
B:ASP674
|
4.9
|
26.3
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5sf5
Go back to
Zinc Binding Sites List in 5sf5
Zinc binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:32.8
occ:1.00
|
O
|
C:HOH946
|
2.1
|
24.4
|
1.0
|
NE2
|
C:HIS529
|
2.2
|
29.0
|
1.0
|
OD2
|
C:ASP564
|
2.2
|
24.8
|
1.0
|
OD1
|
C:ASP674
|
2.2
|
24.3
|
1.0
|
NE2
|
C:HIS563
|
2.2
|
27.6
|
1.0
|
O
|
C:HOH968
|
2.3
|
35.5
|
1.0
|
CG
|
C:ASP674
|
3.1
|
28.2
|
1.0
|
CD2
|
C:HIS529
|
3.1
|
28.5
|
1.0
|
CD2
|
C:HIS563
|
3.1
|
27.8
|
1.0
|
CG
|
C:ASP564
|
3.2
|
24.3
|
1.0
|
CE1
|
C:HIS529
|
3.2
|
30.9
|
1.0
|
OD2
|
C:ASP674
|
3.3
|
33.0
|
1.0
|
CE1
|
C:HIS563
|
3.3
|
25.4
|
1.0
|
OD1
|
C:ASP564
|
3.6
|
25.5
|
1.0
|
MG
|
C:MG802
|
3.8
|
29.0
|
1.0
|
CD2
|
C:HIS525
|
4.1
|
29.6
|
1.0
|
O
|
C:HOH943
|
4.2
|
33.0
|
1.0
|
O
|
C:HOH1024
|
4.2
|
26.0
|
1.0
|
CG
|
C:HIS529
|
4.3
|
26.1
|
1.0
|
CG
|
C:HIS563
|
4.3
|
25.7
|
1.0
|
ND1
|
C:HIS529
|
4.3
|
27.9
|
1.0
|
ND1
|
C:HIS563
|
4.3
|
29.7
|
1.0
|
NE2
|
C:HIS525
|
4.3
|
29.8
|
1.0
|
CB
|
C:ASP564
|
4.4
|
23.6
|
1.0
|
CB
|
C:ASP674
|
4.4
|
29.5
|
1.0
|
O
|
C:HOH966
|
4.6
|
26.8
|
1.0
|
CG2
|
C:VAL533
|
4.8
|
27.8
|
1.0
|
O
|
C:HOH1062
|
4.8
|
42.5
|
1.0
|
CA
|
C:ASP674
|
4.8
|
30.5
|
1.0
|
O
|
C:ASP674
|
4.9
|
27.2
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5sf5
Go back to
Zinc Binding Sites List in 5sf5
Zinc binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2,3- Dimethyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethyl]Imidazo[1,2- B]Pyridazine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:39.1
occ:1.00
|
O
|
D:HOH953
|
2.0
|
29.6
|
1.0
|
O
|
D:HOH982
|
2.1
|
33.6
|
1.0
|
NE2
|
D:HIS529
|
2.2
|
36.0
|
1.0
|
OD2
|
D:ASP564
|
2.2
|
38.9
|
1.0
|
NE2
|
D:HIS563
|
2.2
|
26.2
|
1.0
|
OD1
|
D:ASP674
|
2.3
|
35.2
|
1.0
|
CD2
|
D:HIS563
|
2.9
|
27.6
|
1.0
|
CG
|
D:ASP674
|
3.1
|
37.9
|
1.0
|
CG
|
D:ASP564
|
3.1
|
34.2
|
1.0
|
CD2
|
D:HIS529
|
3.1
|
39.9
|
1.0
|
CE1
|
D:HIS529
|
3.2
|
36.6
|
1.0
|
OD2
|
D:ASP674
|
3.3
|
41.7
|
1.0
|
CE1
|
D:HIS563
|
3.4
|
29.2
|
1.0
|
OD1
|
D:ASP564
|
3.6
|
37.2
|
1.0
|
MG
|
D:MG802
|
3.8
|
37.8
|
1.0
|
O
|
D:HOH934
|
4.1
|
46.3
|
1.0
|
CD2
|
D:HIS525
|
4.1
|
37.4
|
1.0
|
O
|
D:HOH976
|
4.2
|
32.7
|
1.0
|
CG
|
D:HIS563
|
4.2
|
27.8
|
1.0
|
ND1
|
D:HIS529
|
4.3
|
36.0
|
1.0
|
CB
|
D:ASP564
|
4.3
|
34.5
|
1.0
|
CG
|
D:HIS529
|
4.3
|
35.9
|
1.0
|
ND1
|
D:HIS563
|
4.4
|
29.8
|
1.0
|
NE2
|
D:HIS525
|
4.5
|
44.9
|
1.0
|
CB
|
D:ASP674
|
4.5
|
36.8
|
1.0
|
O
|
D:HOH905
|
4.5
|
36.9
|
1.0
|
CG2
|
D:VAL533
|
4.8
|
37.5
|
1.0
|
O
|
D:ASP674
|
4.9
|
34.9
|
1.0
|
CA
|
D:ASP674
|
4.9
|
34.5
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Oct 28 04:50:43 2024
|